Drug and Medication Analysis & Statistics, August 2014 (p5)

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Publishers

All regions

You might be interested in: drug, vaccine, smoking cessation, more »

121-170 of about 4 000 reports

Purchase Reports From Reputable Market Research Publishers

 Hospital Acquired Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections-Pipeline Insights, 2014

Hospital Acquired Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

SUMMARY DelveInsight's,“ Hospital Acquired Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across ...

  • Industries : Drug and Medication
 Insulin Resistance-Pipeline Insights, 2014

Insulin Resistance-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

SUMMARY DelveInsight's,“ Insulin Resistance-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish ...

  • Industries : Drug and Medication
 Local Anesthetic Effect-Pipeline Insights, 2014

Local Anesthetic Effect-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

SUMMARY DelveInsight's,“ Local Anesthetic Effect-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish ...

  • Industries : Drug and Medication
 Metastatic Hormone Refractory Prostate Cancer-Pipeline Insights, 2014

Metastatic Hormone Refractory Prostate Cancer-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

SUMMARY DelveInsight's,“ Metastatic Hormone Refractory Prostate Cancer-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective ...

  • Industries : Drug and Medication
 Methicillin-Susceptible Staphylococcus Aureus (MSSA) Infections-Pipeline Insights, 2014

Methicillin-Susceptible Staphylococcus Aureus (MSSA) Infections-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

SUMMARY DelveInsight's,“ Methicillin-Susceptible Staphylococcus Aureus (MSSA) Infections-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. ...

  • Industries : Drug and Medication
 Opioid Induced Bowel Dysfunction-Pipeline Insights, 2014

Opioid Induced Bowel Dysfunction-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

SUMMARY DelveInsight's,“ Opioid Induced Bowel Dysfunction-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report ...

  • Industries : Drug and Medication
 Opium (Opioid) Addiction-Pipeline Insights, 2014

Opium (Opioid) Addiction-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

SUMMARY DelveInsight's,“ Opium (Opioid) Addiction-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish ...

  • Industries : Drug and Medication
 Smoking Cessation-Pipeline Insights, 2014

Smoking Cessation-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

SUMMARY DelveInsight's,“ Smoking Cessation-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish ...

  • Industries : Drug and Medication
 Substance (Drug) Abuse-Pipeline Insights, 2014

Substance (Drug) Abuse-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

SUMMARY DelveInsight's,“ Substance (Drug) Abuse-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish ...

  • Industries : Drug and Medication
 Vaccines-Pipeline Insights, 2014

Vaccines-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

SUMMARY DelveInsight's,“ Vaccines-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding ...

  • Industries : Drug and Medication
 Vancomycin-Resistant Enterococcus Faecium Infections-Pipeline Insights, 2014

Vancomycin-Resistant Enterococcus Faecium Infections-Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • August 2014
  • by Delve Insight

SUMMARY DelveInsight's,“ Vancomycin-Resistant Enterococcus Faecium Infections-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective ...

  • Industries : Drug and Medication
Global Database of the Top 1000 Pharmaceutical and Medicine Producers - Company Names, Financial Performance, Key Executives, and Contact Details

Global Database of the Top 1000 Pharmaceutical and Medicine Producers - Company Names, Financial Performance, Key Executives, and Contact Details

  • $ 1 317
  • Industry report
  • October 2014
  • by Global Research & Data Services

This company database offers valuable information on top 1000 pharmaceutical and medicine producers in the world which makes the database an invaluable resource for industry executives, marketing, sales ...

  • Industries : Drug and Medication
  • Countries : World
Indonesia Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

Indonesia Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • October 2014
  • by Business Monitor International

BMI View: A strong economy is expected to drive double-digit annual growth in pharmaceutical revenues in Indonesia over our five-year projection period. Multinationals are increasingly viewing the industry ...

  • Industries : Drug and Medication
  • Countries : Indonesia
Moldova Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

Moldova Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • October 2014
  • by Business Monitor International

BMI View: Moldova is projection to deliver a solid US dollar compound annual growth rate (CAGR) of just under 8% for the period from 2010 to 2015, below its rate earlier this decade. The industry is generally ...

  • Industries : Drug and Medication
  • Countries : Moldova, Republic Of
Egypt Pharmaceuticals and Healthcare Report Q4 2014

Egypt Pharmaceuticals and Healthcare Report Q4 2014

  • $ 1 300
  • Industry report
  • October 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: Egypt's relative political stability will lead to a pickup in growth over the coming quarters, increasing the attractiveness of the pharmaceutical market - ...

  • Industries : Drug and Medication
  • Countries : Egypt
Switzerland Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

Switzerland Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • October 2014
  • by Business Monitor International

BMI View: Despite the threat of austerity measures, the Swiss government’s focus on cost-containment within the pharmaceuticals and healthcare segment and the impact of generic competition as a result ...

  • Industries : Drug and Medication
  • Countries : Switzerland
Qatar Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

Qatar Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • October 2014
  • by Business Monitor International

BMI View: Competition is gradually being introduced to Qatar’s pharmaceutical segment, creating opportunities for private segment development in the small but attractive industry . The pharmaceutical ...

  • Industries : Drug and Medication
  • Countries : Qatar
United Kingdom Pharmaceuticals and Healthcare Report Q4 2014

United Kingdom Pharmaceuticals and Healthcare Report Q4 2014

  • $ 1 300
  • Industry report
  • October 2014
  • by Business Monitor International

BMI View: The decline in NHS pharmaceutical expenditure in 2013, despite an increase in prescription numbers, does not come as a surprise and is expected to continue beyond 2014. This drop in spending ...

  • Industries : Drug and Medication
  • Countries : United Kingdom
Morocco Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

Morocco Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • October 2014
  • by Business Monitor International

BMI View: While the depreciation of the local tender will negatively impact industry growth in US dollar terms, the roll-out of the insurance scheme and the elevated inflation will continue to push up ...

  • Industries : Drug and Medication
  • Countries : Morocco
Kuwait Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

Kuwait Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • October 2014
  • by Business Monitor International

BMI View: Kuwait's healthcare system is undergoing a period of transition from a primarily state-run public healthcare system to a rise d number of public-private partnerships (PPPs), which should delive ...

  • Industries : Drug and Medication
  • Countries : Kuwait
Venezuela Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

Venezuela Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • October 2014
  • by Business Monitor International

BMI View: While Venezuela’s distortive policies have damaged the country’s attractiveness for the last twelve years, President Hugo Chavez's taking ill has raised questions about the country’s future ...

  • Industries : Drug and Medication
  • Countries : Venezuela
Finland Pharmaceuticals and Healthcare Report Q4 2104

Finland Pharmaceuticals and Healthcare Report Q4 2104

  • $ 1 300
  • Industry report
  • October 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: An ageing population and the subsequent increased consumption of high-value prescription medicines for the treatment of long-term illnesses will place a greate ...

  • Industries : Drug and Medication
  • Countries : Finland
Greece Pharmaceuticals and Healthcare Report Q4 2104

Greece Pharmaceuticals and Healthcare Report Q4 2104

  • $ 1 300
  • Industry report
  • October 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: The pharmaceutical and healthcare industry in Greece will continue to contract over the remainder of 2014. The government will seek to reduce public spending ...

  • Industries : Drug and Medication
  • Countries : Greece
Russia Pharmaceuticals and Healthcare Report Q4 2104

Russia Pharmaceuticals and Healthcare Report Q4 2104

  • $ 1 300
  • Industry report
  • October 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: Russia's cooling of relations with the West is putting pressure on foreign investment in the country. With the EU and the US applying further sanctions, the ...

  • Industries : Drug and Medication
  • Countries : Russian Federation
Chile Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

Chile Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • October 2014
  • by Business Monitor International

BMI View: Blessed with some of the world's largest reserves of natural resources, many of Latin America's major economies have long been reliant on commodity exports both to support domestic consumption ...

  • Industries : Drug and Medication
  • Countries : Chile
Czech Republic Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

Czech Republic Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • October 2014
  • by Business Monitor International

BMI View: Our expectations that the Czech Republic would return to moderately positive growth in 2011, before seeing negligible growth in 2012 have been revised downwards, and we now project very low growth ...

  • Industries : Drug and Medication
  • Countries : Czech Republic
India Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

India Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • October 2014
  • by Business Monitor International

BMI View: India’s pharmaceutical industry has entered a brief period of relative deterioration, primarily due to the country’s economic slowdown and high inflation, which have negatively affected discretionary ...

  • Industries : Drug and Medication
  • Countries : India
Ghana Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

Ghana Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • October 2014
  • by Business Monitor International

BMI View: Globally, Ghana is ranked as the 74th most attractive industry for pharmaceutical business, out of a total of 84 countries surveyed by our proprietary Business Environment Ratings (BER) matrix. ...

  • Industries : Drug and Medication
  • Countries : Ghana
Malaysia Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

Malaysia Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • October 2014
  • by Business Monitor International

BMI View: Malaysia remains a moderately attractive South-East Asian pharmaceutical industry . Key positives include economic development and the government’s drive to increase biotechnology investment ...

  • Industries : Drug and Medication
  • Countries : Malaysia
South Africa Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

South Africa Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • October 2014
  • by Business Monitor International

BMI View: South Africa's timescale for enacting its National Health Insurance (NHI) scheme is practical and achievable, as are the country’s goals to improve governance, administration and funding. However, ...

  • Industries : Drug and Medication
  • Countries : South Africa
About 15 000 reports

Download Unlimited Documents from Trusted Public Sources

Sanofi - Company Report, October 2014

  • Sanofi Delivers Business Eps() Growth of 10.3% at Cer in Q3 2014
  • October 2014
    25 pages
  • Drug And Medica...  

    Vaccine  

  • United States  

    Europe  

View report >

Medication Market

October 2014

64 Companies

Read our Company Profiles

GlaxoSmithKline P.L.C.

United States

Johnson and Johnson

United States

Novartis Inc.

Switzerland

Icon Group

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.